Payment overview · 2025
General Payments
$147.71
8 reported records · 4 companies
Healthcare provider profile · identity verified
Gregory S. Backofen, M.D.
Allopathic & Osteopathic Physicians|General Practice · EL DORADO, AR · NPI 1619231966
Verified facts
What the public records show
CMS Open Payments records show Gregory S. Backofen, M.D. received $147.71 in general payments during 2025 across 8 reported records.
AstraZeneca Pharmaceuticals LP accounted for 58.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 85 claims for Farxiga by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $86.24 | 58.4% | 5 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $21.32 | 14.4% | 1 | 2025 |
| Paratek Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $20.33 | 13.8% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $19.82 | 13.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $147.71 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $86.24 | 5 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.32 | 1 | 2025 |
Source payment records
|
|||||
| NUZYRA Normalized: nuzyra |
Drug | Paratek Pharmaceuticals, Inc. | $20.33 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 85 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
85 | 14 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 907 | 191 |
| Levothyroxine Sodium | Levothyroxine Sodium | 785 | 158 |
| Amlodipine Besylate | Amlodipine Besylate | 766 | 174 |
| Gabapentin | Gabapentin | 733 | 164 |
| Furosemide | Furosemide | 652 | 151 |
| Potassium Chloride | Potassium Chloride | 536 | 115 |
| Losartan Potassium | Losartan Potassium | 524 | 108 |
| Eliquis | Apixaban | 439 | 54 |
| Pantoprazole Sodium | Pantoprazole Sodium | 408 | 113 |
| Lisinopril | Lisinopril | 374 | 99 |
| Tramadol Hcl | Tramadol Hcl | 340 | 86 |
| Duloxetine Hcl | Duloxetine Hcl | 332 | 66 |
| Omeprazole | Omeprazole | 312 | 70 |
| Sertraline Hcl | Sertraline Hcl | 306 | 49 |
| Metformin Hcl | Metformin Hcl | 301 | 85 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 295 | 59 |
| Tamsulosin Hcl | Tamsulosin Hcl | 290 | 75 |
| Memantine Hcl | Memantine Hcl | 269 | 35 |
| Prednisone | Prednisone | 263 | 160 |
| Clopidogrel | Clopidogrel Bisulfate | 245 | 54 |
| Metoprolol Tartrate | Metoprolol Tartrate | 241 | 55 |
| Quetiapine Fumarate | Quetiapine Fumarate | 241 | 33 |
| Metoprolol Succinate | Metoprolol Succinate | 235 | 60 |
| Montelukast Sodium | Montelukast Sodium | 230 | 61 |
| Trazodone Hcl | Trazodone Hcl | 229 | 46 |
| Meloxicam | Meloxicam | 224 | 57 |
| Alprazolam | Alprazolam | 222 | 39 |
| Simvastatin | Simvastatin | 221 | 51 |
| Donepezil Hcl | Donepezil Hcl | 214 | 33 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 210 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 210 | 55 |
| Escitalopram Oxalate | Escitalopram Oxalate | 199 | 35 |
| Lorazepam | Lorazepam | 185 | 49 |
| Famotidine | Famotidine | 170 | 35 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 168 | 58 |
| Allopurinol | Allopurinol | 159 | 40 |
| Carvedilol | Carvedilol | 151 | 44 |
| Spironolactone | Spironolactone | 150 | 32 |
| Buspirone Hcl | Buspirone Hcl | 147 | 32 |
| Celecoxib | Celecoxib | 142 | 37 |
| Citalopram Hbr | Citalopram Hydrobromide | 141 | 31 |
| Clonazepam | Clonazepam | 138 | 20 |
| Temazepam | Temazepam | 135 | 37 |
| Pregabalin | Pregabalin | 132 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 131 | 36 |
| Ropinirole Hcl | Ropinirole Hcl | 127 | 28 |
| Tizanidine Hcl | Tizanidine Hcl | 122 | 39 |
| Diazepam | Diazepam | 119 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 119 | 34 |
| Budesonide | Budesonide | 114 | 19 |
| Baclofen | Baclofen | 113 | 21 |
| Alendronate Sodium | Alendronate Sodium | 112 | 29 |
| Mirtazapine | Mirtazapine | 112 | 21 |
| Oxybutynin Chloride | Oxybutynin Chloride | 112 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 107 | 30 |
| Fluticasone Propionate | Fluticasone Propionate | 106 | 38 |
| Jardiance | Empagliflozin | 106 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 102 | 27 |
| Glipizide Er | Glipizide | 101 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 100 | 17 |
| Ozempic | Semaglutide | 98 | 22 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 95 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 92 | 37 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 92 | 26 |
| Azithromycin | Azithromycin | 90 | 80 |
| Divalproex Sodium | Divalproex Sodium | 89 | 15 |
| Januvia | Sitagliptin Phosphate | 88 | suppressed |
| Trulicity | Dulaglutide | 88 | 17 |
| Atenolol | Atenolol | 87 | 27 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 85 | 77 |
| Farxiga | Dapagliflozin Propanediol | 85 | 14 |
| Xarelto | Rivaroxaban | 85 | 11 |
| Levetiracetam | Levetiracetam | 84 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 82 | 27 |
| Paroxetine Hcl | Paroxetine Hcl | 81 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 80 | 27 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 79 | 18 |
| Methocarbamol | Methocarbamol | 78 | 29 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 74 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 74 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 73 | suppressed |
| Risperidone | Risperidone | 73 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 73 | 16 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 72 | 48 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 71 | 14 |
| Lactulose | Lactulose | 69 | 20 |
| Finasteride | Finasteride | 67 | 13 |
| Albuterol Sulfate | Albuterol Sulfate | 65 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 65 | 40 |
| Methylprednisolone | Methylprednisolone | 62 | 59 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 61 | 13 |
| Glipizide | Glipizide | 59 | 25 |
| Megestrol Acetate | Megestrol Acetate | 59 | 22 |
| Sucralfate | Sucralfate | 59 | 14 |
| Lamotrigine | Lamotrigine | 58 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 57 | 15 |
| Cilostazol | Cilostazol | 56 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 56 | 24 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 56 | 51 |
| Estradiol | Estradiol | 56 | 18 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 56 | 43 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 56 | 28 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 55 | 15 |
| Metoclopramide Hcl | Metoclopramide Hcl | 55 | suppressed |
| Bumetanide | Bumetanide | 54 | 13 |
| Ezetimibe | Ezetimibe | 54 | 17 |
| Ziprasidone Hcl | Ziprasidone Hcl | 54 | suppressed |
| Bupropion Xl | Bupropion Hcl | 53 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | 11 |
| Primidone | Primidone | 51 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 50 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 50 | 17 |
| Fluconazole | Fluconazole | 49 | 34 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 47 | 41 |
| Cefdinir | Cefdinir | 45 | 37 |
| Ibuprofen | Ibuprofen | 45 | 18 |
| Benazepril Hcl | Benazepril Hcl | 44 | 13 |
| Mounjaro | Tirzepatide | 44 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 43 | 12 |
| Entresto | Sacubitril/Valsartan | 42 | suppressed |
| Fenofibrate | Fenofibrate | 41 | 19 |
| Indomethacin | Indomethacin | 41 | 22 |
| Verquvo | Vericiguat | 40 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 39 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 39 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 37 | suppressed |
| Latanoprost | Latanoprost | 37 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 36 | 11 |
| Enalapril Maleate | Enalapril Maleate | 36 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 36 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | 12 |
| Hydrocortisone | Hydrocortisone | 35 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 34 | 12 |
| Fenofibrate | Fenofibrate,micronized | 34 | suppressed |
| Vascepa | Icosapent Ethyl | 34 | suppressed |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 33 | suppressed |
| Ibu | Ibuprofen | 33 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 32 | 15 |
| Nifedipine Er | Nifedipine | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | 11 |
| Linzess | Linaclotide | 31 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 30 | 28 |
| Doxycycline Hyclate | Doxycycline Hyclate | 30 | 21 |
| Ketoconazole | Ketoconazole | 30 | 14 |
| Ondansetron Odt | Ondansetron | 30 | 24 |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 30 | suppressed |
| Gemtesa | Vibegron | 29 | suppressed |
| Topiramate | Topiramate | 29 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | 15 |
| Cephalexin | Cephalexin | 27 | 20 |
| Gemfibrozil | Gemfibrozil | 27 | suppressed |
| Nitroglycerin | Nitroglycerin | 27 | 19 |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Synthroid | Levothyroxine Sodium | 27 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 27 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 26 | 14 |
| Dilantin | Phenytoin Sodium Extended | 26 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 26 | suppressed |
| Nystatin | Nystatin | 26 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 26 | 13 |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 26 | suppressed |
| Clonidine | Clonidine | 25 | suppressed |
| Eszopiclone | Eszopiclone | 25 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 25 | suppressed |
| Amoxicillin | Amoxicillin | 24 | 20 |
| Lurasidone Hcl | Lurasidone Hcl | 24 | suppressed |
| Novolog Flexpen | Insulin Aspart | 24 | suppressed |
| Haloperidol | Haloperidol | 23 | suppressed |
| Insulin Lispro | Insulin Lispro | 23 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 23 | suppressed |
| Myrbetriq | Mirabegron | 23 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Osphena | Ospemifene | 22 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 22 | suppressed |
| Levofloxacin | Levofloxacin | 21 | 18 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 21 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 21 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 21 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 21 | suppressed |
| Dronabinol | Dronabinol | 20 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | 12 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 19 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 19 | suppressed |
| Dexamethasone | Dexamethasone | 19 | 14 |
| Metolazone | Metolazone | 19 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 18 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 17 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Invokana | Canagliflozin | 17 | suppressed |
| Rivastigmine | Rivastigmine | 17 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Constulose | Lactulose | 16 | suppressed |
| Glimepiride | Glimepiride | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | 13 |
| Acetic Acid | Acetic Acid | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | 11 |
| Diltiazem 12hr Er | Diltiazem Hcl | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Desipramine Hcl | Desipramine Hcl | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Loteprednol Etabonate | Loteprednol Etabonate | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Roflumilast | Roflumilast | 14 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 14 | suppressed |
| Victoza 3-Pak | Liraglutide | 14 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 13 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Belbuca | Buprenorphine Hcl | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Clozapine | Clozapine | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Enbrel | Etanercept | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 12 | suppressed |
| Humulin R | Insulin Regular, Human | 12 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 12 | suppressed |
| Nystop | Nystatin | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Carisoprodol | Carisoprodol | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Etodolac | Etodolac | 11 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 11 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 11 | suppressed |
| Niacin Er | Niacin | 11 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $147.71 · 8 records | AstraZeneca Pharmaceuticals LP | CAPLYTA, FARXIGA, NUZYRA, XIFAXAN | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error